| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $132.76M | $104.18M | $79.94M | $58.93M | $26.29M |
| R&D | $102.93M | $80.08M | $62.52M | $43.01M | $20.64M |
| SG&A | $29.83M | $24.10M | $17.43M | $15.92M | $5.65M |
| Operating Income | -$132.76M | -$104.18M | -$79.94M | -$58.93M | -$26.29M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $2.00K | $1.00K |
| Net Income | -$119.95M | -$86.48M | -$69.13M | -$55.33M | -$26.29M |
| EPS (basic) | -2.0100 | -1.5100 | -1.6200 | -1.3200 | -1.9100 |
| EPS (diluted) | -2.0100 | -1.5100 | -1.6200 | -1.3200 | -1.9100 |
| Shares (diluted) | $59.60M | $57.22M | $42.70M | $41.88M | $13.78M |